After analyzing the microarray data of human brain samples (GSE131282), the mRNA level of ASAP2 was found to increase in the lesions of gray matter from multiple sclerosis (MS) patients compared to the normal regions from MS patients or healthy individuals (Figure 7I). The gene discussed is ASAP2; the disease is myeloid sarcoma.